Chemical, Biological, Radiological, Nuclear, and High Yield Explosives

SAVING LIVES BY MITIGATING MODERN BATTLEFIELD THREATS

Geneva’s CBRNE research focuses on the development, testing, and evaluation of prophylaxis, therapeutics, and diagnostics against CBRNE threats of security concern, with a purpose to develop medical countermeasures to protect the warfighter and maintain maximum global operational capability.

To address the complex challenges posed by CBRNE threats, Geneva’s team of multidisciplinary experts and collaborators are examining key areas:
Detection and Identification: Developing advanced sensors and detection technologies capable of rapidly and accurately detecting various CBRNE agents in diverse environments.

Protection and Personal Equipment: Researching and improving personal protective equipment (PPE), collective protection systems, and decontamination methods to enhance the safety and survivability of military personnel in CBRNE environments.

Medical Countermeasures: Investigating medical treatments, vaccines, antidotes, and therapeutics to mitigate the effects of exposure to CBRNE agents.

Decontamination and Remediation: Developing efficient and environmentally friendly methods for decontaminating equipment, infrastructure, and personnel following exposure to CBRNE agents.

Modeling and Simulation: Utilizing computational modeling and simulation techniques to predict the behavior, spread, and impact of CBRNE agents in different scenarios. This includes developing mathematical models, virtual reality (VR) and augmented reality (AR) simulation software, and predictive analytics to support decision-making and risk assessment.